The National Academy of Medicine (NAM) announced the election of 90 regular members and 10 international members during its annual meeting. Michael J. Lenardo, Chief, Molecular Development of the Immune System Section, at the National Institute of Allergy and Infectious Diseases (NIAID) and a founder of the NIH-Oxford-Cambridge Scholars Program was inducted into NAM this week.
Dr. Lenardo is known for discoveries of molecular mechanisms of immunological tolerance, seminal work on programmed cell death, defining new inherited genetic diseases of immunity, and developing targeted therapies that have saved the lives of children suffering from certain of these devastating diseases. Dr. Lenardo was also elected to the National Academy of Sciences in 2019. Dr. Lenardo said, “It is a tremendous honor both for me and the NIH intramural program and recognizes not simply my efforts, but the many talented trainees and collaborators who worked with dedication on our research. It has been a wonderful adventure in scientific discovery and understanding.”
Election into NAM, which was previously known as the Institute of Medicine, is one of the highest honors in the fields of health and medicine. The academy serves as a source of expertise by providing independent, evidence-based scientific and policy advice to inspire action across the private and public sectors regarding critical issues in health, medicine and science. Of those members, four faculty members of the National Institutes of Health (NIH) have been elected this year. Dr. Michael Lenardo joins Drs. Julie Segre, Luigi D. Notarangelo, Andre Nussenzweig.